Making Cancer Research Dollars Count By Resurrecting Dormant Compounds
Discovering new chemotherapy agents is one of the most difficult tasks in medicinal chemistry, and, given the deepening recession, resources are threatening to hit all-time lows. Of the thousands of active compounds synthesized, very few have progressed beyond early clinical development.
Saturday, April 4, 2009
Subscribe to:
Posts (Atom)
